🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this phase 0 proof-of concept study is to measure the therapeut...
Status
Unknown
Location
Division of Nuclear Medicine, University Hospital Basel
Start Date
2023-03-28
Trial ID
NCT05359146
Treatments Being Tested
This study is to assess if personalized peptide receptor radionuclide thera...
Status
Withdrawn
Location
BC Cancer
Start Date
2023-01-15
Trial ID
NCT04915144
Treatments Being Tested
This is a non-randomized, phase II, open label study. The purpose of this s...
Status
Unknown
Location
Centrum Diagnostyczno-Lecznicze Gammed
Start Date
2019-02-01
Trial ID
NCT04194125
Treatments Being Tested
The purpose of this study is to learn about the feasibility and safety of u...
Status
Active Not Recruiting
Location
Stanford Cancer Institute Palo Alto
Start Date
2021-03-17
Trial ID
NCT04609592
Treatments Being Tested
LEVEL trial aims to demonstrate the higher efficacy of 177Lu-edotreotide ov...
Status
Recruiting
Location
Antwerp University Hospital (UZA)
Start Date
2023-10-27
Trial ID
NCT05918302
Treatments Being Tested
This phase I trial tests the safety and effectiveness of stereotactic body ...
Status
Recruiting
Location
Emory University Hospital Midtown
Start Date
2025-10-14
Trial ID
NCT07150546
In this study, we want to randomize patients with neuroendocrine neoplasms ...
Status
Recruiting
Location
Aarhus University Hospital, department of Nuclear medicine and PET centre
Start Date
2020-02-01
Trial ID
NCT04917484
Treatments Being Tested
The rationale behind the purpose of this study lays on: * the evidence tha...
Status
Unknown
Location
University Hospital of Ferrara
Start Date
2018-07-02
Trial ID
NCT04790708
The purpose of the study is to evaluate efficacy and safety of Peptide Rece...
Status
Active Not Recruiting
Location
Banner Health d.b.a. Banner MD Anderson Cancer Center
Start Date
2017-02-02
Trial ID
NCT03049189
Treatments Being Tested
Peptide Receptor Radionuclide Therapy (PRRT) is based on specific somatosta...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2020-03-09
Trial ID
NCT04385992
Treatments Being Tested